EUVIMEDEUVIMED entdecken
Crossref

Feasibility of symptom monitoring in head and neck cancer follow-up

Simon Müller, Thomas Stadler, Gunesh Rajan, Grégoire Morand, Sara-Lynn Hool, Panagiotis Balermpas, Daniel Schanne, Timo Nannen, Andreas Limacher, Samantha Chan, Sven Trelle, Olgun Elicin und 1 weitere

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S215

DOI: 10.1055/s-0044-1784700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Simon Müller und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Follow-up of head and neck squamous cell carcinoma (HNSCC) consists of regular clinical examinations and periodic imaging. Symptom monitoring is not integrated in current follow-up strategies. This study aims to assess 1) patients" readiness to periodically report symptoms, 2) feasibility of recruitment for a randomized trial integrating patient reported symptoms in follow-up, 3) user friendliness of a HNSCC-specific symptom questionnaire and 4) compliance with periodic symptom reporting. Materials/Methods HNSCC patients with complete response were recruited 6 months after treatment in three Swiss centers. Motivation for trial participation was assessed by pre-screening questionnaire. Enrolled patients were randomly assigned to a standard follow-up or to an experimental follow-up with 6-monthly clinical controls without planned imaging. In the experimental arm, patients report symptoms on paper questionnaires monthly. If symptoms trigger predefined alarms, patients are summoned for clinical examination and imaging is acquired if warranted.

Results

By September 2023, 35 patients completed pre-screening. Thirty patients (86%) declared interest in participation and 23 (66%) were eventually enrolled, along with four patients who had not completed pre-screening. Potential reduction in periodic imaging was the main motivator for participation (52%). The recruitment goal was reached prematurely. Preliminary analysis of user friendliness showed good acceptance of the symptom questionnaire. A majority (63%) favored transition from paper to digital questionnaires. Up-to-date data on user-friendliness and compliance will be presented.

Conclusion

Regular symptom reporting is well received by HNSCC patients. Recruitment for a randomized controlled trial comparing symptom-guided follow-up to the current standard is feasible. Funding information Krebsforschung Schweiz Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Müller, S., Stadler, T., Rajan, G., Morand, G., Hool, S., Balermpas, P., Schanne, D., Nannen, T., Limacher, A., Chan, S., Trelle, S., Elicin, O., & Giger, R. (2024). Feasibility of symptom monitoring in head and neck cancer follow-up. Laryngo-Rhino-Otologie, 103(S 02 S 02), S215. https://doi.org/10.1055/s-0044-1784700

Vancouver

Müller S, Stadler T, Rajan G, Morand G, Hool S, Balermpas P, et al. Feasibility of symptom monitoring in head and neck cancer follow-up. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S215. doi:10.1055/s-0044-1784700

BibTeX
@article{Mller2024,
  author = {Müller, Simon and Stadler, Thomas and Rajan, Gunesh and Morand, Grégoire and Hool, Sara-Lynn and Balermpas, Panagiotis and Schanne, Daniel and Nannen, Timo and Limacher, Andreas and Chan, Samantha and Trelle, Sven and Elicin, Olgun and Giger, Roland},
  title = {Feasibility of symptom monitoring in head and neck cancer follow-up},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S215},
  doi = {10.1055/s-0044-1784700}
}
Kostenlos starten →